Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease
The overwhelming increase in the global incidence of obesity and its associated complications such as insulin resistance, atherosclerosis, pulmonary disease, and degenerative disorders including dementia constitutes a serious public health problem. The Inhibitor of DNA Binding/Differentiation-3 (ID3...
Main Authors: | Vincent Avecilla, Mayur Doke, Quentin Felty |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/6307109 |
Similar Items
-
Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders
by: Mayur Doke, et al.
Published: (2018-01-01) -
Contribution of Inhibitor of Differentiation and Estrogenic Endocrine Disruptors to Neurocognitive Disorders
by: Andrea Avecilla, et al.
Published: (2018-08-01) -
Inhibitor of DNA-Binding/Differentiation Proteins and Environmental Toxicants: Genomic Impact on the Onset of Depressive Dysfunction
by: Vincent Avecilla, et al.
Published: (2019-01-01) -
Endocrine Disrupting Chemicals: Effects on Endocrine Glands
by: Rosa Lauretta, et al.
Published: (2019-03-01) -
Endocrine-Disrupting Chemicals and Infectious Diseases: from Endocrine Disruption to Immunosuppression
by: Elikanah Olusayo Adegoke, et al.
Published: (2021-04-01)